Cold-inducible RNA-binding protein (CIRP) has been identified as an inflammatory mediator that exerts its function in inflammatory diseases. However, the roles of CIRP in patients who received cardiovascular surgery necessitating cardiopulmonary bypass (CPB) are still unknown. The aim of this study was to examine CIRP levels and attempt to evaluate whether CIRP could serve as a predictor for lung dysfunction after cardiovascular surgery.
Background
During cardiovascular surgery, cardiopulmonary bypass (CPB) time is associated with organ dysfunction such as acute renal failure, myocardial dysfunction, and postoperative lung injury [1] [2] [3] . Prolonged CPB time induced by complicated cardiac diseases suggested exaggerated inflammatory responses that resulted in harmful mediators which could cause multiple organs dysfunction [4] . The lung are among the most vulnerable organs during the perioperative period of cardiovascular surgery with CPB [5] . Previous studies showed that 20% of patients who received cardiovascular surgery had acute lung injury during the perioperative period, with a mortality as high as 80% [6] . Those patients would receive much more successful treatment if the lung injury were detected earlier [7, 8] . Therefore, a validated biomarker for lung injury in patients who underwent cardiovascular surgery would be helpful for diagnosis and therapy.
Cold-inducible RNA-binding protein (CIRP) is a 172-amino acid protein that belongs to the cold-shock protein family [9] . It is expressed constitutively at low levels in various tissues, and is upregulated when tissues are subjected to various stimulations, such as hypothermia, hypoxia, and several types of cancer [10] . Furthermore, CIRP plays important roles in tumor suppression or promotion [11, 12] and has deleterious effects during hemorrhagic and septic shock [13] . Increased plasma CIRP is associated with poor prognosis of inflammatory-related diseases [14, 15] , and blockade of endogenous CIRP attenuates the multiple organ dysfunction [16, 17] . It is well known that CIRP initiates a systemic inflammatory responses that leads to undesirable outcomes. However, in contrast to previous studies, a rat model study of deep hypothermic circulatory arrest showed that CIRP exerts its robust renoprotection roles through inhibiting apoptosis activities [18] .
To date, the effects of plasma CIRP on patients who underwent cardiovascular surgery are unclear. In the present study we investigated the variation of plasma CIRP and explored the potential causes. We also assessed the correlation between CIRP and parameters that represent the outcomes of organs and explored whether CIRP could be a predictor for lung injury induced by cardiovascular surgery.
Material and Methods

Trial design and participants
This prospective observational study was conducted at Shanghai General Hospital, Jiaotong University, China. The study protocol and the consent form were approved by the Institutional Ethics Committee of Shanghai General Hospital (Approved number: [2017] 30). The study was registered at chictr.org.cn (ChiCTR-IOR-17012381). Informed consent for participation in the study was obtained from patients who received selective cardiac surgery from 19/6/2017 to 28/3/2018 in Shanghai General Hospital. Patients over 18 years of age who underwent cardiovascular surgery with CPB were included. We excluded patients if they met 1 or more of the following criteria: received immunosuppressive therapy (e.g., corticosteroids), had preoperative history of organ dysfunction, had endocrine disease, had an infection, and patient refusal.
Standard anesthesia and cardiopulmonary bypass protocol
Anesthesia was managed according to a standard protocol, including induction with fentanyl (5-10 µg/kg), midazolam (0.1 mg/kg), and pipecuronium (0.08 mg/kg). Fentanyl, sevoflurane, and pipecuronium were used during anesthesia maintenance.
The CPB circuit, which was identical for all patients, included a microporous hollow fiber membrane oxygenator (Dideco 901, Dideco Liliput, Italy; Medtronic, Inc, Minneapolis, USA) and a Stockert III roll pump (Stockert Instrument; Munich, Germany). Before aortic cannulation, 400 U/kg heparin was administered with the target kaolin-ACT value more than 480 s. The bypass circuit was primed with lactated Ringer's solution 500 ml, hydroxyethyl starch 500 ml, and heparin 2000 IU. Pump flow rates ranged from 3.0 to 4.0 L·min . Core temperature was controlled at 30-32°C using a heat exchanger in the bypass circuit. At the end of CPB, to maintain the fluid balance, modified ultrafiltration was used to remove the excess fluid in the body according to the hematocrit (maintenance of hematocrit >24%) and the monitored blood pressure (aortic blood pressure 85-110/50-80 mmHg, left atrial pressure 5-12 mmHg, and right atrial pressure 5-10 mmHg according to the patient' age and weight). During CPB, myocardial protection strategy was carried out as follows: after aortic cross-clamping, oxygenated blood and cardioplegia solution containing potassium (20 mmol/L) mixed at a 1: 4 ratio at 20°C were infused anterogradely through a cannula at the aortic root to achieve myocardial arrest, and this infusion was repeated every 30-40 min to prevent ischemic damage during CPB.
Blood sample and data collection
Blood samples were collected 1 day before surgery (T 1 ), 6 h after surgery (T 2 ), 1 day after surgery (T 3 ), 3 days after surgery (T 4 ), and 5 days after surgery (T 5 ). All samples were centrifugated at 10 000 rpm for 10 min at 4°C. The plasma supernatants were collected and kept at -80°C until use. Inflammatory mediators -TNF-a, IL-6, IL-10, TLR4, Angiotensin (Ang II), plasminogen activator inhibitor-1(PAI-1), and soluble E-selectin -were measured by enzyme-linked immunosorbent assay (ELISA) following the manufacturer's (CUSABIO) protocol.
Parameters of patients' demographics information, including gender, age, BMI and ASA physical status; the parameters of clinical data during the surgery, such as CPB time and mechanical ventilation time; the scores of sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation II (APACHE II) were recorded or calculated according to patients' clinical data at scheduled time points.
Statistical analysis
Quantitative data are expressed as mean ±SD or median [interquartile range (IQR)], as appropriate. The normality of data distribution was assessed by the Kolmogorov-Smirnov test. The Kruskal-Wallis test or one-way ANOVA was used in statistical analysis to compare differences between groups. Pearson's correlation analysis was conducted to examine the relationship between CIRP and other variables. Multivariate regression analysis was then performed for the independent variables by 'stepwise' method. All the analyses were performed with SPSS software (version 17.0; SPSS Inc., Chicago, USA) and a P value of less than 0.05 was considered statistically significant.
Results
Patient characteristics and clinical data
According to the inclusion/exclusion protocol, 31 patients (17 male and 14 female) patients who underwent cardiovascular surgery during the study period were enrolled. The median patient age was 60 years old. The types of surgeries are summarized in Supplementary Table 1 . The mean CPB time was 88.8±43.3 min during surgeries. After the patients were admitted to the ICU, the mean mechanical ventilation time was 22.0±23.6 h. The nasopharyngeal temperature, hemorrhage volume, and some clinical parameters were recorded and are shown in the Table 1 .
Plasma CIRP levels and laboratory parameters
We measured the variation of CIRP level during cardiovascular surgery and investigated the correlation between laboratory parameters and CIRP levels. As shown in Table 2 , we collected the laboratory parameters (including blood lactate, lymphocyte counts and serum creatinine) and calculated SOFA and APACHE II scores at different time points (Table 2 ). According to the values, even though cardiovascular surgery induced increased lactate, the blood lactate level alone was too low to have effects on outcomes ( In-hospital stay (days) 10 (6-32) of lymphocyte counts may represent the immunosuppression state induced by cardiovascular surgery with CPB ( Table 2) . As shown in Figure 1A , CIRP production was upregulated dramatically and peaked 6 h after cardiovascular surgery (T 2 time point) and the level of CIRP returned to baseline 5 days after cardiovascular surgery (T 5 time point); therefore, we analyzed the correlation between CIRP and other parameters at T 2 time point. Univariate correlation analysis indicated that only SOFA score at T 2 time point was positively correlated with CIRP production (r=0.472, P=0.007) ( Figure 1B , Supplementary Table 2) . Controversially, the SOFA scores at T 2 timepoint show patients may in a good condition with high CIRP production, perhaps due to the balance between proinflammatory states and organ dysfunction.
Correlations between plasma CIRP level and cytokines production
We found that the levels of IL-6 and IL-10 increased significantly 6 h after cardiovascular surgery. The level of IL-6 returned to baseline at 5 days after surgery, while the IL-10 level remained in high until 5 days after surgery (Figure 2A-2D) . However, inconsistent with expectation, there was no significant difference among those time points for TNF-a and TLR4, although there was an increasing trend. Univariate correlation analysis (Supplementary Table 3) showed that plasma CIRP level was positively correlated with IL-6 (r=0.567, P=0.002) and IL-10 (r=0.412, P=0.02) ( Figure 2E -2H) at T 2 time point.
CPB time contributes to the production of plasma CIRP
We analyzed the correlation between CIRP levels and some clinical factors that can affect CIRP production. Univariate analysis indicated that plasma CIRP level was positively correlated with CPB time, as well as inflammatory cytokines (IL-6 and IL-10), at T 2 time point (Supplementary Tables 3, 4) . To investigate the causes of CIRP upregulation, we used a stepwise multiple linear regression model to adjust age, BMI, operation time, CPB time, mechanical time, temperature (during CPB), and inflammatory cytokines (including TNF-a, IL-6, TLR4, and IL-10). Interestingly, CPB time and IL-6 level were associated with CIRP production (CPB time: P=0.013; IL-6: P=0.008) ( Table 3) . Because IL-6 may secreted by macrophages when stimulated with recombinant CIRP, we proposed that the length of CPB time contributed to the increasement of CIRP production (Table 3) .
Plasma CIRP predicts lung injury induced by cardiopulmonary bypass
As shown in Figure 3A- Table 6 ). 
Discussion
In this study, we investigated the roles of perioperative plasma CIRP in patients who underwent cardiovascular surgery with CPB. We reported for the first time that plasma CIRP was significantly upregulated immediately after CPB. The elevated levels were correlated with inflammatory cytokines IL-6 and IL-10. Furthermore, the length of CPB time was associated with CIRP production, while CIRP level was correlated with severity of lung dysfunction. Therefore, plasma CIRP could serve as a predictor for lung injury after cardiovascular surgery with CPB.
CIRP is a highly conserved RNA-binding nuclear protein. It migrates from nucleus to cytoplasm and then releases into the circulation [13] . It exerts its function as a translational regulator for numerous genes or a harmful mediator that induces organ dysfunction [13, 19] . In this study, we found that, compared with preoperative level, plasma CIRP increased immediately after cardiovascular surgery with CPB, and univariate analysis indicated that CIRP is correlated with SOFA scores. These findings suggest CIRP plays detrimental roles during cardiovascular surgery with CPB, in agreement with previous studies [20, 21] .
Besides CIRP production, inflammatory cytokines (e.g., IL-6 and IL-10) exhibit a similar variation tendency after CPB, as described previously [22, 23] . Multiple linear regression analysis indicated that the length of CPB time and IL-6 level contribute to CIRP production. However, Wang et al. found that CIRP derived from macrophages induced IL-6 secretion, which exacerbated organ damage [13, 16] . Based on these findings, Table 3 . Multiple linear regression model analysis of independent risk factors associated with CIRP production 6 h after cardiac surgery. we speculated that the length of CPB time is an important contributor to upregulation of CIRP. Interestingly, our multiple linear regression analysis found that the temperature value we kept during CPB has little effect on CIRP production, but this finding is inconsistent with previous evidence that CIRP is induced by hypothermia [18, 24] . Considering the hypothermia level during CPB, we speculate that the degree of temperature reduction partly explains this strange phenomenon.
As previous studies described, plasma Ang II, PAI-1, and soluble E-selectin partly indicate lung injury [25] [26] [27] . In the present study we found that these proteins increased dramatically and were positively correlated with CIRP production after cardiovascular surgery. Considering that CIRP participates in the dysfunction of endothelial cells via activation of the NLRP3 inflammasome [21] , we speculated that CIRP is correlated with lung injury induced by cardiovascular surgery with CPB. As expected, after adjusting other factors, multiple linear regression analysis indicated that CIRP levels were independently associated with PaO 2 /FiO 2 and reflect the severity of lung injury [28] . These findings strengthen the conclusion that CIRP is a predictor for lung injury after cardiovascular surgery with CPB.
Our study has several limitations. Firstly, inflammatory and stress responses induced by surgeries were different in this study, which may have affected CIRP production. Furthermore, the sample size was too small to make a precise analysis. We did not perform power analysis calculation, although we achieved the expected results. This study is a preliminary investigation of the relationship between CIRP and organ dysfunction during cardiovascular surgery following CPB, and further research is warranted.
Conclusions
CIRP level can act as a biomarker for onset of lung injury after cardiovascular surgery with CPB. Insight into the roles of CIRP in post-cardiovascular surgery provides a potential therapeutic target for pulmonary dysfunction induced by cardiovascular surgery necessitating CPB. 
